Ehsan Malek, Jeries Kort, Leland Metheny, Pingfu Fu, Gen Li, Parameswaran Hari, Yvonne Efebera, Natalie S Callander, Muzaffar H Qazilbash, Sergio Giralt, Amrita Krishnan, Edward A Stadtmauer, Hillard M Lazarus
Obesity is a common health problem among multiple myeloma (MM) patients, and it has been linked to poor clinical outcomes and quality of life (QOL). We conducted a secondary analysis of the BMT CTN 0702, a randomized, controlled trial comparing outcomes of three treatment interventions after a single hematopoietic cell transplant (HCT) (N = 758), to investigate the impact of visceral obesity, as measured by waist-to-hip ratio (WHR), on clinical outcomes and QOL in MM patients. A total of 549 MM patients, median age 55...
January 18, 2024: Transplantation and cellular therapy